Healthcare • Drug Manufacturers - General
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SNY is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
111 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
720 filers reported a long position in SNY for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| DODGE & COX | $1.2B | 28.1M | -4.8% |
| MORGAN STANLEY | $456.6M | 10.7M | -14.5% |
| Fisher Asset Management, LLC | $453.4M | 10.6M | -7.1% |
| BANK OF AMERICA CORP /DE/ | $341.6M | 8M | -15.6% |
| Invesco Ltd. | $290M | 6.8M | +2.7% |
| JPMORGAN CHASE & CO | $285.5M | 6.6M | +17.4% |
| Mondrian Investment Partners LTD | $235.6M | 5.5M | +9.6% |
| BRANDES INVESTMENT PARTNERS, LP | $176.5M | 4.1M | +11.1% |
| FEDERATED HERMES, INC. | $164.2M | 3.8M | -19% |
| Boston Partners | $164M | 3.8M | +6.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.